(Q37283665)

19 August 2017

1 reference

title

Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

3

1 reference

19 August 2017

Aristidis Veves

1

1 reference

PubMed ID

18828198

19 August 2017

Miroslav Backonja

series ordinal

2

1 reference

19 August 2017

1 September 2008

1 reference

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

6

1 reference

19 August 2017

660-674

1 reference

Diabetic somatic neuropathies

19 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Diabetic neuropathies: a statement by the American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The health care costs of diabetic peripheral neuropathy in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The spectrum of neuropathy in diabetes and impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Effects of Presurgical Local Infiltration of Bupivacaine in the Surgical Field on Postsurgical Wound Pain in Laparoscopic Gynecologic Examinations: A Possible Preemptive Analgesic Effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Development of ongoing activity, mechanosensitivity, and adrenaline sensitivity in severed peripheral nerve axons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Peripheral nerve injury triggers central sprouting of myelinated afferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Plasma norepinephrine in sensory diabetic polyneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Ephaptic transmission in chronically damaged peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Local sympathetic denervation in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Impaired skin microvascular reactivity in painful diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The pathogenesis and management of painful diabetic neuropathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

AMPA and NMDA receptor-dependent spinal LTP after nociceptive tetanic stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Potential mechanisms of neuropathic pain in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The natural history of acute painful neuropathy in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The natural history of painful diabetic neuropathy--a 4-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Lifestyle intervention for pre-diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Validation of a modified version of the brief pain inventory for painful diabetic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Development of a neuropathic pain questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Neuropathic pain questionnaire--short form.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The Effect of Intensive Diabetes Therapy on the Development and Progression of Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Antidepressants in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Sodium channel blockade may contribute to the analgesic efficacy of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Antidepressants for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Safety and adverse event profile of duloxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Duloxetine vs. placebo in patients with painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Does treatment with duloxetine for neuropathic pain impact glycemic control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Anticonvulsant drugs for management of pain: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Anticonvulsants in neuropathic pain: rationale and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Anticonvulsant drugs for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Gabapentin for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Pregabalin for the treatment of painful neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Opioids for neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Morphine, gabapentin, or their combination for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

A qualitative systematic review of the role of N-methyl-D-aspartate receptor antagonists in preventive analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Surgical treatment of peripheral neuropathy: outcomes from 100 consecutive decompressions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Practice Advisory: utility of surgical decompression for treatment of diabetic neuropathy: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

A cluster study of predictors of severe West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

New perspectives on the management of diabetic peripheral neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Rational multidrug therapy in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

Early Involvement of the Spinal Cord in Diabetic Peripheral Neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00347.X

10.1111/J.1526-4637.2007.00347.X

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18828198